Low-Dose Interleukin-2 for Refractory Autoimmune Hepatitis

Hepatology. 2018 Oct;68(4):1649-1652. doi: 10.1002/hep.30059.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dose-Response Relationship, Drug
  • Female
  • Hepatitis, Autoimmune / drug therapy*
  • Hepatitis, Autoimmune / pathology*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Interleukin-2 / therapeutic use*
  • Middle Aged
  • Prognosis
  • Sampling Studies
  • Severity of Illness Index
  • Treatment Outcome
  • Young Adult

Substances

  • Immunosuppressive Agents
  • Interleukin-2